https://referensmetodik.folkhalsomyndigheten.se/index.php?action=history&feed=atom&title=Kvantitativ_urinodling-l%C3%A5g_rutinniv%C3%A5_%28screening%2C_Niv%C3%A5_1%29 2026-05-13T22:33:43Z Versionshistorik för denna sida på wikin MediaWiki 1.35.8 https://referensmetodik.folkhalsomyndigheten.se/index.php?title=Kvantitativ_urinodling-l%C3%A5g_rutinniv%C3%A5_(screening,_Niv%C3%A5_1)&diff=6082&oldid=prev 2010-02-09T09:46:27Z

<p><span dir="auto"><span class="autocomment">REFERENSER</span></span></p> <table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="sv"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Äldre version</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Versionen från 9 februari 2010 kl. 09.46</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l34" >Rad 34:</td> <td colspan="2" class="diff-lineno">Rad 34:</td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Joho KL, Soliman H and Weinstein MP. Comparison of one day versus two day incubation of urine cultures. Diagn Microbiol Infect Dis. 1995;21 :55-6.</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Joho KL, Soliman H and Weinstein MP. Comparison of one day versus two day incubation of urine cultures. Diagn Microbiol Infect Dis. 1995;21 :55-6.</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*<del class="diffchange diffchange-inline">MufioS </del>P, Cercenado E, <del class="diffchange diffchange-inline">RodriguezCrixems </del>M, <del class="diffchange diffchange-inline">Dfaz </del>MD, Vicente T, Bouza E. The CLED agar option in urine culture routine. Diagn Microbiol Infect Dis 1992;15:287-90.</div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*<ins class="diffchange diffchange-inline">Munios </ins>P, Cercenado E, <ins class="diffchange diffchange-inline">Rodriguez-Creixems </ins>M, <ins class="diffchange diffchange-inline">Diaz </ins>MD, Vicente T, Bouza E. The CLED agar option in urine culture routine. Diagn Microbiol Infect Dis 1992;15:287-90.</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Murray P, Traynor P, Hopson D. Evaluation of microbiological processing of urine Specimens: Comparison of overnight versus two day incubation. J Clin Microbiol 1992;30:1600..1</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Murray P, Traynor P, Hopson D. Evaluation of microbiological processing of urine Specimens: Comparison of overnight versus two day incubation. J Clin Microbiol 1992;30:1600..1</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*<del class="diffchange diffchange-inline">Navari-o </del>F, Fuentes 1, Izquierdo C, Sanchez F, Prats G. <del class="diffchange diffchange-inline">[</del>Evaluation of chromogenic medium <del class="diffchange diffchange-inline">cs 1D2 </del>(bioMerieux) in urine cultures. Spanish Enfermedades Infecciosas Y Microbioiogia Clinica 1996; 14:215-9.</div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*<ins class="diffchange diffchange-inline">Navarro </ins>F, Fuentes 1, Izquierdo C, Sanchez F, Prats G. Evaluation of chromogenic medium <ins class="diffchange diffchange-inline">CPS ID2 </ins>(bioMerieux) in urine cultures. Spanish Enfermedades Infecciosas Y Microbioiogia Clinica 1996;14:215-9.</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Referensmetodik för svampinfektioner 110, SMI-tryck-nr 121-1998.  </div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Referensmetodik för svampinfektioner 110, SMI-tryck-nr 121-1998.  </div></td></tr> </table>

Magnus Thore https://referensmetodik.folkhalsomyndigheten.se/index.php?title=Kvantitativ_urinodling-l%C3%A5g_rutinniv%C3%A5_(screening,_Niv%C3%A5_1)&diff=5047&oldid=prev 2009-12-22T14:33:46Z

<p><span dir="auto"><span class="autocomment">Substrat</span></span></p> <table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="sv"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Äldre version</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Versionen från 22 december 2009 kl. 14.33</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l16" >Rad 16:</td> <td colspan="2" class="diff-lineno">Rad 16:</td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==== Substrat ====</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==== Substrat ====</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*CLED-agar (för kontrollstammar se [[Urin-bilaga 1]])<del class="diffchange diffchange-inline">. Observera att det inte är tillräckligt att i stället använda [[Kvantitativ urinodling-hög rutinnivå|kromagar]] som ensamt medium</del>.</div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*CLED-agar (för kontrollstammar se [[Urin-bilaga 1]]).</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==== Inokulering ====</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==== Inokulering ====</div></td></tr> </table>

Magnus Thore https://referensmetodik.folkhalsomyndigheten.se/index.php?title=Kvantitativ_urinodling-l%C3%A5g_rutinniv%C3%A5_(screening,_Niv%C3%A5_1)&diff=5046&oldid=prev 2009-12-22T14:33:00Z

<p><span dir="auto"><span class="autocomment">Substrat</span></span></p> <table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="sv"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Äldre version</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Versionen från 22 december 2009 kl. 14.33</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l16" >Rad 16:</td> <td colspan="2" class="diff-lineno">Rad 16:</td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==== Substrat ====</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==== Substrat ====</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*CLED-agar (för kontrollstammar se <del class="diffchange diffchange-inline">Bilaga </del>1). Observera att det inte är tillräckligt att i stället använda [[Kvantitativ urinodling-hög rutinnivå|kromagar]] som ensamt medium.</div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*CLED-agar (för kontrollstammar se <ins class="diffchange diffchange-inline">[[Urin-bilaga </ins>1<ins class="diffchange diffchange-inline">]]</ins>). Observera att det inte är tillräckligt att i stället använda [[Kvantitativ urinodling-hög rutinnivå|kromagar]] som ensamt medium.</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==== Inokulering ====</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==== Inokulering ====</div></td></tr> </table>

Magnus Thore https://referensmetodik.folkhalsomyndigheten.se/index.php?title=Kvantitativ_urinodling-l%C3%A5g_rutinniv%C3%A5_(screening,_Niv%C3%A5_1)&diff=5038&oldid=prev 2009-12-22T14:19:54Z

<p>flyttade <a href="/w/Kvantitativ_urinodling-l%C3%A5g_rutinniv%C3%A5_(screening)" class="mw-redirect" title="Kvantitativ urinodling-låg rutinnivå (screening)">Kvantitativ urinodling-låg rutinnivå (screening)</a> till <a href="/w/Kvantitativ_urinodling-l%C3%A5g_rutinniv%C3%A5_(screening,_Niv%C3%A5_1)" title="Kvantitativ urinodling-låg rutinnivå (screening, Nivå 1)">Kvantitativ urinodling-låg rutinnivå (screening, Nivå 1)</a></p> <table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface"> <tr class="diff-title" lang="sv"> <td colspan="1" style="background-color: #fff; color: #202122; text-align: center;">← Äldre version</td> <td colspan="1" style="background-color: #fff; color: #202122; text-align: center;">Versionen från 22 december 2009 kl. 14.19</td> </tr><tr><td colspan="2" class="diff-notice" lang="sv"><div class="mw-diff-empty">(Ingen skillnad)</div> </td></tr></table>

Magnus Thore https://referensmetodik.folkhalsomyndigheten.se/index.php?title=Kvantitativ_urinodling-l%C3%A5g_rutinniv%C3%A5_(screening,_Niv%C3%A5_1)&diff=4524&oldid=prev 2009-12-16T15:10:00Z

<p></p> <table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="sv"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Äldre version</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Versionen från 16 december 2009 kl. 15.10</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l11" >Rad 11:</td> <td colspan="2" class="diff-lineno">Rad 11:</td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Denna metod betraktas som låg rutinnivå (Nivå 1) för urinodling vid mikrobiologiskt laboratorium.</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Denna metod betraktas som låg rutinnivå (Nivå 1) för urinodling vid mikrobiologiskt laboratorium.</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>Lägsta koncentration som kan besvaras med denna metod är <del class="diffchange diffchange-inline">10e7 </del>CFU/L (<del class="diffchange diffchange-inline">10e4 </del>CFU/mL).</div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>Lägsta koncentration som kan besvaras med denna metod är <ins class="diffchange diffchange-inline">&lt;math&gt;10^7&lt;/math&gt; </ins>CFU/L (<ins class="diffchange diffchange-inline">&lt;math&gt;10^4&lt;/math&gt; </ins>CFU/mL).</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> </table>

Magnus Thore https://referensmetodik.folkhalsomyndigheten.se/index.php?title=Kvantitativ_urinodling-l%C3%A5g_rutinniv%C3%A5_(screening,_Niv%C3%A5_1)&diff=3795&oldid=prev 2009-12-01T10:25:47Z

<p><span dir="auto"><span class="autocomment">REFERENSER</span></span></p> <table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="sv"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Äldre version</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Versionen från 1 december 2009 kl. 10.25</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l38" >Rad 38:</td> <td colspan="2" class="diff-lineno">Rad 38:</td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Murray P, Traynor P, Hopson D. Evaluation of microbiological processing of urine Specimens: Comparison of overnight versus two day incubation. J Clin Microbiol 1992;30:1600..1</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Murray P, Traynor P, Hopson D. Evaluation of microbiological processing of urine Specimens: Comparison of overnight versus two day incubation. J Clin Microbiol 1992;30:1600..1</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*Navari-o F, Fuentes 1, Izquierdo C, Sanchez F, Prats G. [<del class="diffchange diffchange-inline">Evaluatjon </del>of <del class="diffchange diffchange-inline">chromogenjc </del>medium cs 1D2 (bioMerieux) in urine cultures<del class="diffchange diffchange-inline">}</del>. <del class="diffchange diffchange-inline">[Spanishi </del>Enfermedades <del class="diffchange diffchange-inline">Infeccjosas </del>Y <del class="diffchange diffchange-inline">Microbioiogja </del>Clinica 1996; 14:215-9.</div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*Navari-o F, Fuentes 1, Izquierdo C, Sanchez F, Prats G. [<ins class="diffchange diffchange-inline">Evaluation </ins>of <ins class="diffchange diffchange-inline">chromogenic </ins>medium cs 1D2 (bioMerieux) in urine cultures. <ins class="diffchange diffchange-inline">Spanish </ins>Enfermedades <ins class="diffchange diffchange-inline">Infecciosas </ins>Y <ins class="diffchange diffchange-inline">Microbioiogia </ins>Clinica 1996; 14:215-9.</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Referensmetodik för svampinfektioner 110, SMI-tryck-nr 121-1998.  </div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Referensmetodik för svampinfektioner 110, SMI-tryck-nr 121-1998.  </div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Reisner BS, Austin EF. Evaluation of CPS ID 2 chromogenic agar as a single medium for urine culture. Diagn Microbiol Infect Dis 1997;28: 113-7.</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Reisner BS, Austin EF. Evaluation of CPS ID 2 chromogenic agar as a single medium for urine culture. Diagn Microbiol Infect Dis 1997;28: 113-7.</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*Samra Z, Heifetz M, Talmor J, Barn E, Bahar 3. Evaluation of use of a new <del class="diffchange diffchange-inline">cliromogenic </del>agar in detection of urinary tract pathogens. 3 Clin Microbiol 1998;36:990-4.</div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*Samra Z, Heifetz M, Talmor J, Barn E, Bahar 3. Evaluation of use of a new <ins class="diffchange diffchange-inline">chromogenic </ins>agar in detection of urinary tract pathogens. 3 Clin Microbiol 1998;36:990-4.</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Willinger B, Manafi M. Evaluation of a new chromogenic agar medium for the identification of urinary tract pathogens. Letters in Applied Microbiology 1995;20 :300-2.</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Willinger B, Manafi M. Evaluation of a new chromogenic agar medium for the identification of urinary tract pathogens. Letters in Applied Microbiology 1995;20 :300-2.</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Kategori:Laboratoriediagnostik-urinvägsinfektioner]]</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Kategori:Laboratoriediagnostik-urinvägsinfektioner]]</div></td></tr> </table>

Magnus Thore https://referensmetodik.folkhalsomyndigheten.se/index.php?title=Kvantitativ_urinodling-l%C3%A5g_rutinniv%C3%A5_(screening,_Niv%C3%A5_1)&diff=2351&oldid=prev 2009-10-23T14:26:53Z

<p><span dir="auto"><span class="autocomment">REFERENSER</span></span></p> <table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="sv"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Äldre version</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Versionen från 23 oktober 2009 kl. 14.26</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l30" >Rad 30:</td> <td colspan="2" class="diff-lineno">Rad 30:</td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Clarridge JE, Johnson JR, Pezzio MT. Laboratory diagnosis of urinary tract infections. Cumitech 2B. Washington: American Society for Microbiology, 1998.</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Clarridge JE, Johnson JR, Pezzio MT. Laboratory diagnosis of urinary tract infections. Cumitech 2B. Washington: American Society for Microbiology, 1998.</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*Kouri T Ed. et al. ECLM European Urinalysis Guidelines. Scand J Clin Lab Invest 2000;60:Suppl 231.</div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*<ins class="diffchange diffchange-inline">[[Urin-bilaga 3|</ins>Kouri T Ed. et al.<ins class="diffchange diffchange-inline">]] </ins>ECLM European Urinalysis Guidelines. Scand J Clin Lab Invest 2000;60:Suppl 231.</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Joho KL, Soliman H and Weinstein MP. Comparison of one day versus two day incubation of urine cultures. Diagn Microbiol Infect Dis. 1995;21 :55-6.</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Joho KL, Soliman H and Weinstein MP. Comparison of one day versus two day incubation of urine cultures. Diagn Microbiol Infect Dis. 1995;21 :55-6.</div></td></tr> </table>

Magnus Thore https://referensmetodik.folkhalsomyndigheten.se/index.php?title=Kvantitativ_urinodling-l%C3%A5g_rutinniv%C3%A5_(screening,_Niv%C3%A5_1)&diff=2327&oldid=prev 2009-10-23T13:00:32Z

<p><span dir="auto"><span class="autocomment">Substrat</span></span></p> <table class="diff diff-contentalign-left diff-editfont-monospace" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="sv"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Äldre version</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Versionen från 23 oktober 2009 kl. 13.00</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l16" >Rad 16:</td> <td colspan="2" class="diff-lineno">Rad 16:</td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==== Substrat ====</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==== Substrat ====</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*CLED-agar (för kontrollstammar se Bilaga 1). Observera att det inte är tillräckligt att i stället använda kromagar som ensamt medium. <del class="diffchange diffchange-inline"> </del></div></td><td class='diff-marker'>+</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*CLED-agar (för kontrollstammar se Bilaga 1). Observera att det inte är tillräckligt att i stället använda <ins class="diffchange diffchange-inline">[[Kvantitativ urinodling-hög rutinnivå|</ins>kromagar<ins class="diffchange diffchange-inline">]] </ins>som ensamt medium.</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div> </div></td><td colspan="2"> </td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==== Inokulering ====</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==== Inokulering ====</div></td></tr> </table>

Magnus Thore https://referensmetodik.folkhalsomyndigheten.se/index.php?title=Kvantitativ_urinodling-l%C3%A5g_rutinniv%C3%A5_(screening,_Niv%C3%A5_1)&diff=2326&oldid=prev 2009-10-23T12:59:35Z

<p>Skapade sidan med &#039;&#039;&#039;Till innehållsförteckningen för <a href="/w/Referensmetodik:_Urinv%C3%A4gsinfektioner/bakteriuri,_2:a_upplagan_2000" title="Referensmetodik: Urinvägsinfektioner/bakteriuri, 2:a upplagan 2000">Referensmetodik: Urinvägsinfektioner/bakteriuri, 2:a upplagan 2000</a>&#039;&#039; ---- == Kvantitativ urinodling - Nivå 1 - Låg rutinnivå eller …&#039;</p> <p><b>Ny sida</b></p><div>&#039;&#039;Till innehållsförteckningen för [[Referensmetodik: Urinvägsinfektioner/bakteriuri, 2:a upplagan 2000]]&#039;&#039;<br /> <br /> ----<br /> <br /> == Kvantitativ urinodling - Nivå 1 - Låg rutinnivå eller screening ==<br /> <br /> <br /> <br /> === Metodbeskrivning ===<br /> <br /> Denna metod betraktas som låg rutinnivå (Nivå 1) för urinodling vid mikrobiologiskt laboratorium.<br /> <br /> Lägsta koncentration som kan besvaras med denna metod är 10e7 CFU/L (10e4 CFU/mL).<br /> <br /> <br /> ==== Substrat ====<br /> <br /> *CLED-agar (för kontrollstammar se Bilaga 1). Observera att det inte är tillräckligt att i stället använda kromagar som ensamt medium. <br /> <br /> <br /> ==== Inokulering ====<br /> <br /> 1 μL inokuleras med plastögla på CLED-agar. Inokulatet sprids på samma sätt som tidigare beskrivits.<br /> <br /> *Inkubering och avläsning<br /> **CLED-agar 35-37 °C, aerobt, 1 dygn.<br /> <br /> <br /> == REFERENSER ==<br /> <br /> *Clarridge JE, Johnson JR, Pezzio MT. Laboratory diagnosis of urinary tract infections. Cumitech 2B. Washington: American Society for Microbiology, 1998.<br /> <br /> *Kouri T Ed. et al. ECLM European Urinalysis Guidelines. Scand J Clin Lab Invest 2000;60:Suppl 231.<br /> <br /> *Joho KL, Soliman H and Weinstein MP. Comparison of one day versus two day incubation of urine cultures. Diagn Microbiol Infect Dis. 1995;21 :55-6.<br /> <br /> *MufioS P, Cercenado E, RodriguezCrixems M, Dfaz MD, Vicente T, Bouza E. The CLED agar option in urine culture routine. Diagn Microbiol Infect Dis 1992;15:287-90.<br /> <br /> *Murray P, Traynor P, Hopson D. Evaluation of microbiological processing of urine Specimens: Comparison of overnight versus two day incubation. J Clin Microbiol 1992;30:1600..1<br /> <br /> *Navari-o F, Fuentes 1, Izquierdo C, Sanchez F, Prats G. [Evaluatjon of chromogenjc medium cs 1D2 (bioMerieux) in urine cultures}. [Spanishi Enfermedades Infeccjosas Y Microbioiogja Clinica 1996; 14:215-9.<br /> <br /> *Referensmetodik för svampinfektioner 110, SMI-tryck-nr 121-1998. <br /> *Reisner BS, Austin EF. Evaluation of CPS ID 2 chromogenic agar as a single medium for urine culture. Diagn Microbiol Infect Dis 1997;28: 113-7.<br /> <br /> *Samra Z, Heifetz M, Talmor J, Barn E, Bahar 3. Evaluation of use of a new cliromogenic agar in detection of urinary tract pathogens. 3 Clin Microbiol 1998;36:990-4.<br /> <br /> *Willinger B, Manafi M. Evaluation of a new chromogenic agar medium for the identification of urinary tract pathogens. Letters in Applied Microbiology 1995;20 :300-2.<br /> <br /> [[Kategori:Laboratoriediagnostik-urinvägsinfektioner]]</div>

Magnus Thore